We are live on ! Find out more
AIM

Alerce Investment Management Portfolio holdings

AUM $56.8M
1-Year Est. Return 31.17%
This Fund
S&P 500
This Quarter Est. Return
-23.26%
1 Year Est. Return
+31.17%
3 Year Est. Return
+25.12%
5 Year Est. Return
10 Year Est. Return
AUM
$75.7M
AUM Growth
-$11.3M
Cap. Flow
+$15.4M
Cap. Flow %
20.37%
Top 10 Hldgs %
100%
Holding
6
New
Increased
2
Reduced
Closed

Top Buys

Rank Stock Value
1
ANNX icon
Annexon
ANNX
+$14.6M
2
AKBA icon
Akebia Therapeutics
AKBA
+$852K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANNX icon
1
Annexon
ANNX
$834M
$27.2M 35.9%
7,056,024
+2,647,058
+60% +$14.6M
AMWL icon
2
American Well
AMWL
$180M
$24.7M 32.67%
523,786
WHWK
3
Whitehawk Therapeutics
WHWK
$190M
$11.8M 15.6%
1,630,830
AKBA icon
4
Akebia Therapeutics
AKBA
$354M
$9.08M 12%
16,205,119
+1,115,000
+7% +$852K
ASMB icon
5
Assembly Biosciences
ASMB
$498M
$1.87M 2.47%
185,625
RNTX
6
Rein Therapeutics
RNTX
$63.1M
$1.03M 1.36%
830,466

Similar funds

Alerce Investment Management's Q1 2023 Portfolio in Review

As of Q1 2023, Alerce Investment Management held 6 positions worth $75.7M, down 13% from $86.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Alerce Investment Management deployed $15.4M of net new capital in Q1 2023, adding to 2 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Alerce Investment Management added most to Annexon in Q1 2023, an estimated $14.6M increase.
  • Alerce Investment Management's ten largest holdings make up 100% of its $75.7M portfolio in Q1 2023.
  • Alerce Investment Management opened 0 new positions and closed 0 in Q1 2023.
  • Alerce Investment Management's portfolio value fell 13% quarter-over-quarter to $75.7M.

Based on Alerce Investment Management's 13F filing for Q1 2023, filed 15 May 2023.